
Roche Holding AG
RHHVF | OTC
$443.30
+$8.75 (+2.01%)
At close: Sep 21, 2026, 3:57 PM ET
$443.30
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
TTM Period Ending | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 63.49B | 62.4B | 60.58B | 59.6B | 60.77B | 63.28B | 64.38B | 62.8B | 59.76B | 58.32B | 60.28B |
Cost of Revenue | 16.56B | 16.28B | 15.75B | 15.82B | 16.63B | 18.84B | 20.22B | 19.71B | 17.69B | 16.36B | 16.99B |
Gross Profit | 46.93B | 46.11B | 43.94B | 42.9B | 44.14B | 44.44B | 44.17B | 43.1B | 42.06B | 41.96B | 43.28B |
Operating Income | 14.68B | 13.42B | 14.7B | 15.09B | 17.36B | 18.18B | 18.33B | 17.28B | 17.11B | 17.72B | 18.38B |
Interest Income | 260M | 260M | 25.5M | 195M | 326.5M | 284M | 214M | 171M | 187.5M | 211M | 220M |
Pretax Income | 13.16B | 11.79B | 13.15B | 14.11B | 14.55B | 16.37B | 18.52B | 17.4B | 17.67B | 17.97B | 16.45B |
Net Income | 9.43B | 8.28B | 10.62B | 11.5B | 11.03B | 12.42B | 14.66B | 13.93B | 14.02B | 14.3B | 12.96B |
Selling & General & Admin | 15.03B | 14.9B | 13.35B | 13.29B | 12.86B | 12.03B | 11.98B | 11.87B | 11.65B | 11.82B | 12.72B |
Research & Development | 14.59B | 15.3B | 14.33B | 13.23B | 13.72B | 14.05B | 13.65B | 13.71B | 13.06B | 12.15B | 11.92B |
Other Expenses | 2.63B | 2.5B | 307M | -62M | n/a | n/a | -136M | -136M | -144M | -265M | -266M |
Operating Expenses | 32.25B | 32.7B | 27.98B | 26.55B | 26.78B | 26.27B | 25.84B | 25.82B | 24.95B | 24.24B | 24.9B |
Interest Expense | 1.4B | 1.4B | 592M | 997M | 755M | 350M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 2.55B | 2.55B | 2.59B | 4.74B | 4.59B | 4.7B | 5.13B |
Cost & Expenses | 48.81B | 48.98B | 45.88B | 44.52B | 43.4B | 45.11B | 46.06B | 45.52B | 42.65B | 40.6B | 41.9B |
Income Tax Expense | 2.84B | 2.61B | 1.64B | 1.72B | 2.58B | 2.8B | 2.62B | 2.46B | 2.85B | 2.9B | 2.77B |
Shares Outstanding (Basic) | 802.82M | 802.31M | 802.31M | 797.24M | 799M | 799.18M | 809.3M | 844.96M | 854M | 855M | 855M |
Shares Outstanding (Diluted) | 803M | 802M | 802M | 804M | 804M | 799.18M | 810M | 857.47M | 862M | 863.7M | 866M |
EPS (Basic) | 11.83 | 10.32 | 13.27 | 14.40 | 13.80 | 15.41 | 17.79 | 16.39 | 16.41 | 16.72 | 15.15 |
EPS (Diluted) | 11.75 | 10.32 | 13.22 | 14.30 | 13.75 | 15.40 | 17.68 | 16.20 | 16.25 | 16.53 | 14.96 |
EBITDA | 23.43B | 22.72B | 21.04B | 19.91B | 21.03B | 22B | 22.41B | 21.73B | 21.75B | 22.29B | 22.82B |
EBIT | 15.23B | 13.2B | 16.63B | 12.6B | 7.44B | 12.27B | 18.33B | 17.28B | 17.11B | 17.72B | 18.38B |
Depreciation & Amortization | 3.15B | 3.1B | 3.04B | 3.3B | 3.67B | 3.82B | 4.08B | 4.45B | 4.64B | 4.57B | 4.44B |
Add to Watchlist
Select watchlists to add or remove RHHVF